[Skip to Navigation]
Poster Presentations: American Head and Neck Society
August 2006

P186 p53 and Bcl-xL Expression Predicts Outcome in Patients With Oropharynx Cancer Treated With Chemoradiation

Arch Otolaryngol Head Neck Surg. 2006;132(8):901. doi:10.1001/archotol.132.8.901-a

Objective: To assess tumor markers in oropharynx cancer.

Design: Marker expression and clinical outcome.

Setting: Laboratory.

Patients: Forty-two patients with advanced oropharyngeal cancer treated with chemoradiation therapy.

Intervention: Treatment with chemoradiation therapy.

Main Outcome Measures: Expression of p53 and Bcl-xL in tumor tissues was assessed for correlation with chemotherapy response and survival.

Add or change institution